AVIR
Atea Pharmaceuticals Inc
5.20$
-2.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | – | |
| – | -1.8% | +3.5% | +1.1% | -4.4% | +17.5% | -51.4% | -32.9% | -3.2% | +1.5% | -18.7% | -9.3% | – | |
| – | +27.5% | +49.8% | -181.4% | – | – | – | – | -322.6% | – | -122.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +104.5% | +119.5% | -197.9% | -97.2% | – | -82.1% | +170.1% | +12.8% | -36.2% | +15.4% | – | |
| – | – | – | – | – | – | – | +2,705.8% | -16.0% | – | -99.5% | +465.2% | – | |
| – | -100.0% | – | -100.0% | – | -100.0% | – | +3,961.4% | -19.8% | -100.0% | – | -100.0% | – | |
| – | – | +187.8% | +382.7% | -275.7% | – | – | -157.9% | – | – | -189.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.